Skip to Main Content
Table 6.

Benefits and Strength of Evidence Comparing Sugammadex with Neostigmine for Incidence of Residual Neuromuscular Blockade and Time to Recovery to Train-of-four Ratio Greater than or Equal to 0.9

Benefits and Strength of Evidence Comparing Sugammadex with Neostigmine for Incidence of Residual Neuromuscular Blockade and Time to Recovery to Train-of-four Ratio Greater than or Equal to 0.9
View large
Benefits and Strength of Evidence Comparing Sugammadex with Neostigmine for Incidence of Residual Neuromuscular Blockade and Time to Recovery to Train-of-four Ratio Greater than or Equal to 0.9
View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal